Overview
PHARMAGEST INTERACTIVE - CIP
Pharmagest Inter@ctive develops software that helps French pharmacies keep everything under control. The company makes LGPI and other pharmacy management software for stock management, supply order management, drug interaction alerting, account management, and medicinal expense claim forms management functions. France-based pharmaceutical distributor Groupe CERP Lorraine owns more than 60% of the company, which also shares a chairman with CERP
...
Read More Lorraine.
Read Less
Read More Lorraine.
Read Less
Thierry Frédéric Nicolas CHAPUSOT
See more contacts
Computer Systems Design and Related Services
,
Professional, Scientific, and Technical Services
,
Custom computer programming services
Accounting, Tax Preparation, Bookkeeping, and Payroll Services
,
Advertising, Public Relations, and Related Services
,
Architectural, Engineering, and Related Services
,
Legal Services
,
Management, Scientific, and Technical Consulting Services
,
Other Professional, Scientific, and Technical Services
,
Scientific Research and Development Services
,
Specialized Design Services
?
?
?
Actual
?
Actual
$238.90 million
Actual
2.67%
1.45%
$394
DEC
?
?
Euronext Paris:EQS
Contacts
Get in Touch with 13 Principals*
-
Thierry Frédéric Nicolas CHAPUSOTChairman of the Board
-
Contact 2?
-
Contact 3?
-
Contact 4?
Dynamic search and list-building capabilities
Real-time trigger alerts
Comprehensive company profiles
Valuable research and technology reports
Financial Statements
Dun & Bradstreet collects private company financials for more than 23 million companies worldwide. Find out more.
Financial data as of December 31, 2023 (12 month period) in USD
Annual Revenue 2023
$238.90 million
USD
Actual
1 USD = 0.92 EUR
All financial statement data is in millions except per share data | Source: Morningstar
| Cash Flow (mil) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Net Operating Cash | $63 | $62 | $52 |
| Net Investing Cash | -$51 | -$23 | -$39 |
| Net Financing Cash | -$17 | -$39 | -$11 |
| Net Change in Cash | -$5 | $0 | $2 |
| Cash at Beginning of Period | $25 | $25 | $37 |
| Cash at End of Period | $20 | $25 | $38 |
| Capital Expenditure | -$20 | -$11 | -$11 |
| Assets (mil) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Current Assets | |||
| Cash and Cash Equivalents | $20 | $25 | $38 |
| Accounts Receivable | $57 | $51 | $41 |
| Inventories | $11 | $10 | $10 |
| Other Current Assets | $55 | $63 | $45 |
| Asset Summary | |||
| Total Current Assets | $144 | $149 | $133 |
| Tangible Fixed Assets | $36 | $29 | $30 |
| Intangible Assets | $44 | $42 | $43 |
| Total Assets | $394 | $351 | $330 |
| Liabilities (mil) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Current Liabilities | |||
| Accounts Payable | $17 | $18 | $18 |
| Short-Term Debt | $21 | $17 | $ |
| Other Current Liabilities | $79 | $72 | $85 |
| Liability Summary | |||
| Total Current Liabilities | $118 | $107 | $102 |
| Long-Term Debt | $43 | $45 | $ |
| Other Long-Term Liabilities | $3 | $0 | $0 |
| Total Liabilities | $181 | $167 | $179 |
| Stakeholder's Equity (mil) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Equity | |||
| Common Stock | $3 | $3 | $3 |
| Retained Earnings | $51 | $50 | $43 |
| Equity Summary | |||
| Total Equity | $238 | $206 | $173 |
| Shares Outstanding | 15,031,235 | 15,031,697 | 15,019,717 |